# BREKIYA

NDC: 64896-509
Generic name: Dihydroergotamine Mesylate
Labeler / Manufacturer: Amneal Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20250516

FDA application: NDA215400

## Active ingredients

- DIHYDROERGOTAMINE MESYLATE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64896-509"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64896-509
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cdbf5619-767f-4165-aec2-17bdd92d9ca2